Piramal Pharma Limited (BOM:543635)
239.25
-0.15 (-0.06%)
At close: Nov 20, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 318.09 billion as of November 20, 2026. Its market cap has increased by 26.88% in one year.
Market Cap
318.09B
Enterprise Value
368.75B
Revenue
97.79B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 318.09B, an increase of 40.30%. That is a compound annual growth rate of 8.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 318.09B | 39.11% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 619.94B |
| Gland Pharma | 549.34B |
| Ipca Laboratories | 466.56B |
| Emcure Pharmaceuticals | 443.66B |
| Ajanta Pharma | 414.52B |
| Wockhardt | 353.36B |
| Piramal Pharma | 317.20B |
| Alembic Pharmaceuticals | 205.40B |